rss
Sex Transm Infect 2009;85:405-406 doi:10.1136/sti.2009.036780
  • Short report

Commentary

  1. D Goldmeier1,
  2. D Richardson2
  1. 1
    Imperial College NHS Trust at St Mary’s Hospital, London, UK
  2. 2
    Lawson Unit Royal Sussex County Hospital, Brighton, UK
  1. Dr David Goldmeier, Imperial College NHS Trust at St Mary’s Hospital, London W2 1NY, UK; david.goldmeier{at}imperial.nhs.uk
  • Accepted 23 April 2009

The article by Crosby and colleagues1 in the current edition of the journal suggests that the use of phosphodiesterase 5 inhibitors (PDE5i) (sildenafil, tadalafil and vardenafil) by men is associated with a significantly increased rate of condom breakage compared with men who use condoms but not PDE5i. This seems biologically plausible in that whatever the degree of a man’s natural penile rigidity, PDE5i use can enhance that intensity of tumescence.2

The use of PDE5i in HIV and other sexually transmitted infection (STI) acquisition and transmission is of importance, particularly in men who have sex with men (MSM). In clinical practice it would seem logical …

[Full text of this article]

This Article

  1. Extract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.